Drug Database
Back to search

France· FR:68942820

GLUCOVANCE 500 mg/2,5 mg, comprimé pelliculé

A medicinal product containing glibenclamide + chlorhydrate de metformine, registered in France by MERCK SANTE.

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedGLUCOVANCE 500 mg/2,5 mg, comprimé pe…ATC—REGISTER NO.FR:68942820PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about glibenclamide + chlorhydrate de metformineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
GLIBENCLAMIDE + CHLORHYDRATE DE METFORMINE
Manufacturer
MERCK SANTE
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400935801623
    plaquette(s) PVC-Aluminium de 30 comprimé(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Glibenclamide + chlorhydrate de metformine in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glibenclamide + chlorhydrate de metformine products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Czechia · Glibomet
  • Italy · Diaglimet, Glibomet
  • Portugal · Glucovance
  • Romania · Bidiab, Glibomet
  • Slovenia · Glucovance
  • Slovakia · Glibomet

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f4f4989f-99cb-4fde-919e-f02203b2ed6a
GET /v1/drugs/f4f4989f-99cb-4fde-919e-f02203b2ed6a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68942820",
  "date_amm": "2001-10-18",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "GLIBENCLAMIDE + CHLORHYDRATE DE METFORMINE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about glibenclamide + chlorhydrate de metformine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console